Companies › ONCY

ONCOLYTICS BIOTECH INC COM NEW (ONCY)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001129928 · EDGAR filings · Updated 2026-07-24

ONCOLYTICS BIOTECH INC COM NEW (ONCY) has reported institutional ownership of 2.6%, with 57 institutional managers holding positions valued at $2.61M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-13 — Current report (8-K) filed
• 2026-07-08 — Current report (8-K) filed
• 2026-06-16 — Current report (8-K) filed
• 2026-06-03 — Initial insider ownership filed (Form 3)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ONCOLYTICS BIOTECH INC COM NEW has 57 institutional holders and institutional ownership of 2.6%.

Insider activity

Insiders reported 14 transactions (14 buys, 0 sells) across 12 reporting insiders, with a net reported value of $363.2K.

Data flags from SEC filings

Related companies

Celularity Inc (CELU) · Lantern Pharma Inc (LTRN) · SERINA THERAPEUTICS INC (SER) · Bolt Biotherapeutics Inc (BOLT) · BIOATLA INC (BCAB) · CEL SCI Corp (CVM)